Stephen L. Rawlings

Array ( [id] => 5348781 [patent_doc_number] => 20090004142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'A CELL THERAPY METHOD FOR THE TREATMENT OF TUMORS' [patent_app_type] => utility [patent_app_number] => 11/782264 [patent_app_country] => US [patent_app_date] => 2007-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 25048 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004142.pdf [firstpage_image] =>[orig_patent_app_number] => 11782264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574893 [patent_doc_number] => 07833526 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Methods of modulating apoptosis by administration of relaxin agonists or antagonists' [patent_app_type] => utility [patent_app_number] => 11/781872 [patent_app_country] => US [patent_app_date] => 2007-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29809 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/833/07833526.pdf [firstpage_image] =>[orig_patent_app_number] => 11781872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279514 [patent_doc_number] => 20090131646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Novel bag proteins and nucleic acid molecules encoding them' [patent_app_type] => utility [patent_app_number] => 11/879274 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 10882 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131646.pdf [firstpage_image] =>[orig_patent_app_number] => 11879274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 120804 [patent_doc_number] => 07709000 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Antibody recognizing a small subset of human hematopoietic cells' [patent_app_type] => utility [patent_app_number] => 11/879460 [patent_app_country] => US [patent_app_date] => 2007-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15391 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709000.pdf [firstpage_image] =>[orig_patent_app_number] => 11879460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802624 [patent_doc_number] => 20080014211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic and therapeutic purposes' [patent_app_type] => utility [patent_app_number] => 11/879078 [patent_app_country] => US [patent_app_date] => 2007-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19142 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014211.pdf [firstpage_image] =>[orig_patent_app_number] => 11879078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391224 [patent_doc_number] => 20090208537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Anti-Neovasculature Preparations for Cancer' [patent_app_type] => utility [patent_app_number] => 11/772811 [patent_app_country] => US [patent_app_date] => 2007-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13030 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208537.pdf [firstpage_image] =>[orig_patent_app_number] => 11772811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5199779 [patent_doc_number] => 20070299097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Strategy for Leukemia Therapy' [patent_app_type] => utility [patent_app_number] => 11/771453 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9148 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299097.pdf [firstpage_image] =>[orig_patent_app_number] => 11771453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5028400 [patent_doc_number] => 20070269847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'METHODS, PHARMACEUTICAL FORMULATIONS AND KITS FOR IDENTIFICATION OF SUBJECTS AT RISK FOR CANCER' [patent_app_type] => utility [patent_app_number] => 11/770946 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11364 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20070269847.pdf [firstpage_image] =>[orig_patent_app_number] => 11770946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903475 [patent_doc_number] => 20080112888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'IGFBP2 BIOMARKER' [patent_app_type] => utility [patent_app_number] => 11/771454 [patent_app_country] => US [patent_app_date] => 2007-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25955 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20080112888.pdf [firstpage_image] =>[orig_patent_app_number] => 11771454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8282483 [patent_doc_number] => 08216582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Polynucleotides and polypeptide sequences involved in cancer' [patent_app_type] => utility [patent_app_number] => 12/305648 [patent_app_country] => US [patent_app_date] => 2007-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 107 [patent_figures_cnt] => 107 [patent_no_of_words] => 51310 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12305648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588799 [patent_doc_number] => 20100061996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING HEPSIN ACTIVATION OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR' [patent_app_type] => utility [patent_app_number] => 12/306217 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 46415 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061996.pdf [firstpage_image] =>[orig_patent_app_number] => 12306217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807465 [patent_doc_number] => 20080171043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same' [patent_app_type] => utility [patent_app_number] => 11/811303 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 28848 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171043.pdf [firstpage_image] =>[orig_patent_app_number] => 11811303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465002 [patent_doc_number] => 20090325202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Methods for Developing and Assessing Therapeutic Agents' [patent_app_type] => utility [patent_app_number] => 12/308005 [patent_app_country] => US [patent_app_date] => 2007-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18608 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325202.pdf [firstpage_image] =>[orig_patent_app_number] => 12308005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764631 [patent_doc_number] => 20080175842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT' [patent_app_type] => utility [patent_app_number] => 11/754196 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46129 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175842.pdf [firstpage_image] =>[orig_patent_app_number] => 11754196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 141266 [patent_doc_number] => 07691376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/753221 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 14519 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691376.pdf [firstpage_image] =>[orig_patent_app_number] => 11753221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5248068 [patent_doc_number] => 20070244302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Antibodies And Methods For Generating Genetically Altered Antibodies With High Affinity' [patent_app_type] => utility [patent_app_number] => 11/746868 [patent_app_country] => US [patent_app_date] => 2007-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15172 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244302.pdf [firstpage_image] =>[orig_patent_app_number] => 11746868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367707 [patent_doc_number] => 20090305266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'TEST FOR OVARIAN CANCER BY DETECTING ABNORMALITY IN FANCD2 PATHWAY' [patent_app_type] => utility [patent_app_number] => 12/299233 [patent_app_country] => US [patent_app_date] => 2007-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 25715 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20090305266.pdf [firstpage_image] =>[orig_patent_app_number] => 12299233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4595511 [patent_doc_number] => 07981628 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Monoclonal antibodies and their use' [patent_app_type] => utility [patent_app_number] => 12/298761 [patent_app_country] => US [patent_app_date] => 2007-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33699 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981628.pdf [firstpage_image] =>[orig_patent_app_number] => 12298761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538719 [patent_doc_number] => 20090220524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'THERAPEUTIC AGENTS FOR ALZHEIMER\'S DISEASE AND CANCER' [patent_app_type] => utility [patent_app_number] => 12/298151 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14269 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220524.pdf [firstpage_image] =>[orig_patent_app_number] => 12298151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797125 [patent_doc_number] => 20080008711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers' [patent_app_type] => utility [patent_app_number] => 11/788254 [patent_app_country] => US [patent_app_date] => 2007-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14543 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20080008711.pdf [firstpage_image] =>[orig_patent_app_number] => 11788254 [rel_patent_id] =>[rel_patent_doc_number] =>)